Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00204373
Status:
COMPLETED
Last Update Posted:
2012-10-30
First Post:
2005-09-13
Brief Title:
Treatment of Zollinger-Ellison Syndrome With Prevacid
Sponsor:
Charles Mel Wilcox MD
Organization:
University of Alabama at Birmingham
Organization Data
Organization:
University of Alabama at Birmingham
Class:
OTHER
Study ID:
F030107005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Charles Mel Wilcox MD
Lead Sponsor Class:
OTHER
Responsible Party:
Charles Mel Wilcox MD
Responsible Party Title:
Prinicle Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Alabama at Birmingham
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Takeda Pharmaceuticals North America Inc | INDUSTRY |